Inhibitory effects of the medicinal herb,Thonningia san gunea,on liver drug metabolizing enzymes of rats

Abstract

In this study we examined the effect of the aqueous extract of Thonningia sanguinea (T.S.) on 7-ethoxyresorufin 0- deethylase (EROD, CYPlAl), 7-pentoxyresorufin-dealkylase (PROD, CYP2B1/2), 7-methoxyresorufin 0- demethylase (MROD, CYP1A2), aniline hydroxylase (aniline, CYP2E1), p-nitrophenol hydroxylase (PNPH, CYP2E1) and erythromycin N-demethylase (ERDM, CYP3A1) in rat liver in vitro and in vivo. Although T.S. extract increased ERDM activity in induced rat liver microsomes, it showed a dose-dependent inhibitory effectin vitro on other P450 monooxygenase activities particularly EROD and PROD, which are mediated primarily by CYPlAl and CYP2B1/2, respectively. PROD, EROD and MROD activities were also decreased by 18%, 19% and 40%, respectively, in hepatic microsomes prepared from rats treated with T.S. extract for 3 days. Kinetic analysis of CYP activity of 3-methylchloranthrene-induced microsomes demonstrated that T.S. inhibited EROD and MROD activities by a noncompetitive and competitive mechanism, respectively. The analysis of alterations produced by T.S. on PROD kinetic parameters in phenobarbital-induced microsomes suggested that the inhibition is noncompetitive. Pretreatment of rats with T.S. prolonged pentobarbital and phenobarbital sleeping time; however, plasma phenobarbital concentration determined on awakening showed no significant difference between control and T.S.-treated rats. T.S. was also found to be a potent inhibitor of the liver cytosolic glutathione S-transferase. These data suggest that selective modulation of CYP isoenzymes by T.S. might con-tribute to protection of the liver from xenobiotic-induced intoxication or to alteration of the action of drug (s) conco-mitantly administered besides its antioxidative properties.

Keywords

T. sanguinea antioxidant medicinal herb cytochrome P450 barbiturate sleeping tim

References

1 Nyarko AK , Addy ME . In vitro screening for the anti-anaphylactic agent in Thonningia sanguinea . J Ethno-pharmacol 1994; 41: 45-51 .

2 Gyamfi MA , Yonamine M , Aniya Y . Free-radical scavenging action of medicinal herbs from Ghana: Thonningia sanguinea on experimentally-induced liver injuries . Gen Pharmacol 1999; 32 661-667 .

3 Gyamfi MA , Aniya Y . Medicinal herb, Thonningia sanguinea protects against aflatoxin B1 acute hepato-toxicity in Fischer 344 rats . Hum Exp Toxicol 1998; 17 418-423 .

4 Nelson DR , et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature . DNA Cell Biol 1993; 12: 1-51 .

5 Guengerich FP . Reactions and significance of cyto-chrome P450 enzymes . J Biol Chem 1991; 26 10019-10022 .

6 Armstrong RN . Glutathione S-transferase: reaction mechanism, structure and function . Chem Res Toxicol 1991; 4: 131-139 .

7 Birner G , Bernauer U , Werner M , Dekant W . Biotransfor-mation, excretion and nephrotoxicity of haloalkene-derived cysteine S-conjugates . Arch Toxicol 1997; 72: 1-8 .

8 Anders MW , Dekant W . Glutathione-dependent bioactivation of haloalkenes . Annu Rev Pharmacol Toxicol 1998; 38: 501-537 .

9 Bailey DG , et al. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics . Clin Pharmacol Ther 1993; 54 589-594 .

10.

10 Bailey DG , Spence JD , Munoz C , Arnold JMO . Interaction of citrus juices with felodipine and nifedipine . Lancet 1991; 337: 268-269 .

11.

11 Yee GC , et al. Effect of grapefruit juice on blood cyclosporin concentration . Lancet 1995; 346: 955-956 .

12.

12 Ducharme MP , Warbasse LH , Edwards DJ . Disposition of intravenous and oral cyclosporine after administration with grapefruit juice . Clin Pharmacol Ther 1995; 57: 485-491 .

13.

13 Somogyi A , Muirhead M . Pharmacokinetic interactions of cimetidine . Clin Pharmacokinet 1987; 12: 321-366 .

14.

14 Wargovich MJ , Goldberg MT . Diallyl sulfide . A naturally occurring thioether that inhibits carcinogen-induced nuclear damage to colon epithelial cells in vivo . Mutat Res 1985; 143: 127-129 .

15.

15 Hong JY et al. Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung . Carcinogenesis 1992; 13: 901-904 .

16.

16 Wargovich MJ , Imada O , Stephens LC . Initiation and post-initiation chemopreventive effects of diallyl sulfide in esophageal carcinogenesis . Cancer Lett 1992; 64: 39-42 .

17.

17 Peterson FJ , Knodell RG , Lindemann NJ , Steele NM . Prevention of acetaminophen and cocaine hepatotoxicity in mice by cimetidine treatment . Gastroenterology 1983; 85: 122-129 .

18.

18 Ohtani II , et al. Thonningianins A and B, new antioxidants from the African medicinal herb Thonningia sanguinea . J Nat Prod 2000; 63: 676-679 .

19.

19 Chung KT , et al. Tannins and human health: a review . Crit Rev Food Sci Nutr 1998; 38 421-464 .

20.

20 Lubet RA , et al. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome (s) P-450 by phenobarbital and other xenobiotics in the rat . Arch Biochem Biophys 1985; 238 43-48 .

21.

21 Nash T . The colorimetrical estimation of formaldehyde by means of the Hantzsch reaction . Biochem J 1985; 55 416-421 .

22.

22 Imai Y , Ito A , Sato R . Evidence for biochemically different types of vesicles in the hepatic microsomal fraction . J Biochem (Tokyo) 1966; 60 417-428 .

23.

23 Koop DR . Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P450 isozyme 3a . Mol Pharmacol 1986; 29 399-404 .

24.

24 Habig WH , Pabst MJ , Jakoby WB . Glutathione S-transferases. The first enzymatic step in mercapturic acid formation . J Biol Chem 1974; 249: 7130-7139 .

25.

25 Lowry OH , Rosebrough NJ , Farr AL , Randall RJ . Protein measurement with Folin phenol reagent . J Biol Chem 1951; 193: 265-275 .

26.

26 Reed DJ , et al. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide and related thiols and disulfides . Anal Biochem 1980; 106 55-62 .

27.

27 Nerurkar PV , et al. Methoxyresorufin and benzyloxyr-esorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse . Biochem Pharmacol 1993; 46 933-943 .

28.

28 Burke MD , et al. Ethoxy-, pentoxy-and benzyloxyphe-noxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450 . Biochem Pharmacol 1985; 34 3337-3345 .

29.

29 Burke MD , et al. Cytochrome P450 specificities of alkoxyresorufin 0-dealkylation in human and rat liver . Biochem Pharmacol 1994; 48 923-936 .

30.

30 Jugert FK , et al. Multiple cytochrome P450 isozymes in murine skin: induction of P450 1A, 2B, 2E, and 3A by dexamethasone . J Invest Dermatol 1994; 102 970-975 .

31.

31 Stresser DM , Bjeldanes LF , Bailey GS , Williams DE . The anticarcinogen 3,3'-diindolylmethane is an inhibitor of cytochrome P-450 . J Biochem Toxicol 1995; 10: 191-201 .

32.

32 Kadlubar FF , Hammons GJ . The role of cytochrome P450 in the metabolism of chemical carcinogens. In: Guen-gerich FP (Ed.), Mammalian Cytochromes P450, Vol. II. CRC Press, Boca Raton, FL , 1987, pp. 81-130.

33.

33 Wilson NM , et al. Binding and metabolism of benzo [a]-pyrene and 7,12-dimethylbenz [a] anthracene by seven purified forms of cytochrome P-450 . Carcinogenesis 1984; 5 1475-1483 .

34.

34 Guengerich FP . Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy . Cancer Res 1988; 48: 2946-2954 .

35.

35 Guo Z , Smith TJ , Ishizaki H , Yang CS . Metabolism of isozymes of microsomal cytochrome P450 in rats, rabbits and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel elec-trophoresis . Biochemistry 1991; 21 1698-1706 .

36.

36 Doehmer J , et al. Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin Bl . Proc Nat] Acad Sci USA 1988; 85 5769-5773 .

37.

37 Ishii K , Maeda K , Kamataki T , Kato R . Mutagenic activation of aflatoxin BI by several forms of purified cytochrome P-450 . Mutat Res 1986; 174 85-88 .

38.

38 Yoshizawa H , et al. Metabolism and activation of aflatoxin Bi by reconstituted cytochrome P-450 system of rat liver . Cancer Res 1982; 42: 1120-1124 .

39.

39 Ueng YF , Kuwabara T , Chun YJ , Guengerich FP . Cooperativity in oxidations catalyzed by cytochrome P450 3A4 . Biochemistry 1997; 36: 370-381 .

40.

40 Shou M , et al. Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site . Biochemistry 1994; 33 6450-6645 .

41.

41 Raney KD , et al. Oxidation of aflatoxins and sterigma-tocystin by human liver microsomes: significance of aflatoxin Q, as a detoxication product of aflatoxin Bl . Chem Res Toxicol 1992; 5: 202-210 .

42.

42 Halvorson MR , Safe SH , Parkinson A , Phillips TD . Aflatoxin Bi hydroxylation by the pregnenolone-16 alpha-carbonitrile-inducible form of rat liver microso-mal cytochrome P-450 . Carcinogenesis 1988; 9: 2103-2108 .

43.

43 Ryan DE , Thomas PE , Reik LM , Levin W . Purification, characterization and regulation of five rat hepatic microsomal cytochrome P-450 isozymes . Xenobiotica 1982; 12: 727-744 .

44.

44 Freitas JC , et al. Effect of beta-myrcene on pentobarbital sleeping time . Braz J Med Biol Res 1993; 26: 519-523 .

45.

45 Freudenthal RI , Carroll Fl . Metabolism of certain commonly used barbiturates . Drug Metab Rev 1973; 2: 265-278 .

46.

46 Brodie BB , Shore PA , Silver SL . Potentiating action of chlorpromazine and reserpine . Nature 1955; 4489 1133-1134 .

47.

47 André P , Descotes J , Simonet R , Evreux JC . Reappraisal of the barbiturate sleeping time in mice as predictive tool for the detection of liver enzymes inhibiting drugs . Methods Find Exp Clin Pharmacol 1984; 12: 582-587 .

48.

48 Griffeth LK , Rosen GM , Rauckman EJ . Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine . Drug Metab Dispos 1984; 12: 582-587 .

49.

49 Jakoby WB . The glutathione S-transferases . Adv En-zymol Relat Areas Mol Biol 1978; 46: 383-414 .

50.

50 Boyer TD . The glutathione S-transferases: an update . Hepatology 1989; 9 486-496 .

51.

51 Das M , Bickers DR , Mukhtar H . Plant phenols as in vitro inhibitors of glutathione S-transferase (s) . Biochem Biophys Res Commun 1984; 120 427-433 .

52.

52 Das M , Singh SV , Mukhtar H , Awasthi YC . Differential inhibition of rat and human glutathione S-transferase isozymes by plant phenols . Biochem Biophys Res Commun 1986; 141 1170-1176 .

53.

53 Van Bladeren PJ . Influence of non-nutrient plant components on biotransformation enzymes . Biomed Pharmacother 1997; 51: 324-327 .

54.

54 Das M , Bickers DR , Mukhtar H . Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action . Carcinogenesis 1985; 6: 1409-1413 .

55.

55 Oetari S , et al. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver . Biochem Pharmacol 1996; 51 39-45 .

56.

56 Susan M , Rao MN . Induction of glutathione S-transferase activity by curcumin in mice . Arzneim-Forsch 1992; 42 962-964 .

57.

57 Van Bladeren PJ , van-der-Gen A , Breimer DD , Mohn GR . Stereoselective activation of vicinal dihalogen compounds to mutagens by glutathione conjugation . Biochemical Pharmacol 1979; 28 2521-2524 .

58.

58 Van Bladeren PJ , Breimer DD , Rotteveel-Smijs GM , de-Jong RA , Buijs W , van-der-Gen A , Mohn GR . The role of glutathione conjugation in the mutagenicity of 1,2-dibromoethane . Biochem Pharmacol 1980; 29 2975-2982 .